ATS 2019 Virtual Final Program

P350 Not a Parapneumonia Pleural Effusion. It Was a Neuroendocrine Carcinoma/ W. Rodriguez, O.J. Cantres, M.A. Ortiz-Bonilla, San Juan, Puerto Rico, p.A7018 P351 Cardiac Tamponade: A Rare Presentation of Non-Small Cell Lung Cancer/ A. Agrawal, A. Gautam, B. Yegneswaran, New Brunswick, NJ, p.A7019 P352 Carcinoid Tumors of Lung and BRCA Mutations: Is There a Connection Between Them?/ M.Z. Shariff, V. Gupta, S. Gor, H. Qaisar, J. Mikhail, Neptune, NJ, p.A7020 P353 Necrotizing Cavitary Lung Lesion: A Case of Primary Mucinous Adenocarcinoma/ A. Hines, A. Iftikhar, A.A. Patel, V.R. Thakkar, A. Adial, L. Sanso, Flushing, NY, p.A7021 BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL WORKSHOP CME Credits Available: 1.5 WS7 CRISPR: BREAKING BAD FOR THE GOOD OF ADVANCING SCIENCE R Registration Fee: $75 (includes box lunch) Attendance is limited. Pre-registration is required. Assemblies on Respiratory Structure and Function; Allergy, Immunology and Inflammation; Behavioral Science and Health Services Research; Clinical Problems; Critical Care; Environmental, Occupational and Population Health; Nursing; Pediatrics; Pulmonary Circulation; Pulmonary Infections and Tuberculosis; Pulmonary Rehabilitation; Respiratory Cell and Molecular Biology; Sleep and Respiratory Neurobiology; Thoracic Oncology 11:45 a.m. - 1:15 p.m. KBHCCD Room C144-C145 (Level 1) Target Audience Faculty, staff, postdoctoral/clinical fellows, and graduate students interested in either starting or advancing their work in the field of CRISPR/Cas9 molecular biology Objectives At the conclusion of this session, the participant will be able to: • learn the applications and the various means of delivery of CRISPR/Cas9 gene editing presently being utilized in, but not limited to, the respiratory field; • learn how this technique is continually being modified and perfected for different contexts; • understand the advantages and limitations of the ever evolving gene editing technique of CRISPR/Cas9. Leading scientists primarily from the field of respiratory gene editing will provide a comprehensive overview of their work utilizing CRISPR/Cas9 gene editing with a focus on methods, applications and implications of this novel technique. Limitations and future directions will be discussed by the speaker panel. Chairing: S. Siddiqui, PhD, Frisco, TX M.J. O’Sullivan, PhD, BS, Boston, MA ATS 2019 • Dallas, TX WEDNESDAY • MAY 22 367 WEDNESDAY MID-DAY Wednesday Mid-day, May 22